MIF and neoplasm: Additionally, specific inhibitors such as 4-iodo-6-phenylpyrimidine have been employed to disrupt MIF signaling, markedly enhancing tumor cell sensitivity to chemotherapy, suppressing primary tumor growth and angiogenesis, and significantly reducing the incidence of distant metastasis (57).